Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Moreno

Showing results (361-370 of 403) with videos related to

Pageof 41
Sort By:
Nanoimpact|March 26, 2026
Facile preparation of environmentally relevant nano- and microplastics for hazard assessment and ecotoxicological testing evaluationJ J Reinosa, J C Guzmán, M Fernández-Álvarez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2013
Pharmacogenetic predictors of severe peripheral neuropathy in colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy: a GEMCAD group studyA Custodio, J Moreno-Rubio, J Aparicio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Antitumor activity of lurbinectedin (PM01183) and doxorubicin in relapsed small-cell lung cancer: results from a phase I studyE Calvo, V Moreno, M Flynn, et al.
Medicina Clinica|December 7, 1996
[Rapid and slow progression of the infection by the type 1 human immunodeficiency virus in a population of seropositive subjects in Madrid]V Soriano, R Martín, J del Romero, et al.
Hepatology (Baltimore, Md.)|March 11, 2009
Intramitochondrial crystalline inclusions in nonalcoholic steatohepatitisStephen H Caldwell, Luiz Antonio R de Freitas, Sang H Park, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 7, 2015
GEINOFOTE: efficacy and safety of fotemustine in patients with high-grade recurrent gliomas and poor performance statusP Pérez-Segura, R Manneh, I Ceballos, et al.
Annual Review of Food Science and Technology|June 28, 2024
How Diet and Lifestyle Can Fine-Tune Gut Microbiomes for Healthy AgingM Tamayo, M Olivares, P Ruas-Madiedo, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|September 15, 2012
Clinicopathological risk factors of Stage II colon cancer: results of a prospective studyC Santos, A López-Doriga, M Navarro, et al.
ESMO Open|August 29, 2022
Lurbinectedin, a selective inhibitor of oncogenic transcription, in patients with pretreated germline BRCA1/2 metastatic breast cancer: results from a phase II basket studyV Boni, B Pistilli, I Braña, et al.
Journal of Investigational Allergology & Clinical Immunology|January 28, 2022
Sensitization Phenotypes in Immediate Hypersensitivity to Cephalosporins: A Cluster Analysis StudyM V Campanón-Toro, E M Moreno, A Gallardo, et al.
Pageof 41

Showing results (361-370 of 403) with videos related to

Sort By:
Pageof 41
Nanoimpact|March 26, 2026
Facile preparation of environmentally relevant nano- and microplastics for hazard assessment and ecotoxicological testing evaluationJ J Reinosa, J C Guzmán, M Fernández-Álvarez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2013
Pharmacogenetic predictors of severe peripheral neuropathy in colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy: a GEMCAD group studyA Custodio, J Moreno-Rubio, J Aparicio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Antitumor activity of lurbinectedin (PM01183) and doxorubicin in relapsed small-cell lung cancer: results from a phase I studyE Calvo, V Moreno, M Flynn, et al.
Medicina Clinica|December 7, 1996
[Rapid and slow progression of the infection by the type 1 human immunodeficiency virus in a population of seropositive subjects in Madrid]V Soriano, R Martín, J del Romero, et al.
Hepatology (Baltimore, Md.)|March 11, 2009
Intramitochondrial crystalline inclusions in nonalcoholic steatohepatitisStephen H Caldwell, Luiz Antonio R de Freitas, Sang H Park, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 7, 2015
GEINOFOTE: efficacy and safety of fotemustine in patients with high-grade recurrent gliomas and poor performance statusP Pérez-Segura, R Manneh, I Ceballos, et al.
Annual Review of Food Science and Technology|June 28, 2024
How Diet and Lifestyle Can Fine-Tune Gut Microbiomes for Healthy AgingM Tamayo, M Olivares, P Ruas-Madiedo, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|September 15, 2012
Clinicopathological risk factors of Stage II colon cancer: results of a prospective studyC Santos, A López-Doriga, M Navarro, et al.
ESMO Open|August 29, 2022
Lurbinectedin, a selective inhibitor of oncogenic transcription, in patients with pretreated germline BRCA1/2 metastatic breast cancer: results from a phase II basket studyV Boni, B Pistilli, I Braña, et al.
Journal of Investigational Allergology & Clinical Immunology|January 28, 2022
Sensitization Phenotypes in Immediate Hypersensitivity to Cephalosporins: A Cluster Analysis StudyM V Campanón-Toro, E M Moreno, A Gallardo, et al.
Pageof 41